Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 1


Figure 1 Kaplan-Meier Survival Curves in PAH Patients

Survival was assessed from the date of operation in patients receiving transplantation and from the date of acceptance as lung transplant candidates in patients treated medically. The survival was significantly better in patients receiving living-donor lobar lung transplantation (LDLLT) than in patients medically treated. p = 0.028, log-rank test. CLT = cadaveric lung transplantation; PAH = pulmonary arterial hypertension.